A randomized, single-blind, single-dose study evaluating the pharmacokinetic equivalence of proposed biosimilar ABP 980 and trastuzumab in healthy male subjects
Crossref DOI link: https://doi.org/10.1007/s00280-017-3286-9
Published Online: 2017-03-24
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hanes, Vladimir
Chow, Vincent
Zhang, Nan
Markus, Richard
License valid from 2017-03-24